chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown.    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Apr-2021, Coronavirus test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's second vaccination is scheduled for 29Apr2021 and Ihe want to know that whether he can go ahead and get it on that date?   Reporter did not allow further contact
Patient received 2 doses of GARDASIL vaccine spaced 2 months apart, 3 weeks following both doses developed erythematous, itchy rash over the neck. After second dose rash over the neck, face, arms, back and chest as well.
2nd dose was administered on 6-2-21. It was supposed to be given 6-12-21
Pt received first dose of Moderna COVID-19 vaccine on 12/9/2021. Around 12/30/2021 she developed SOB which worsened over 2 days. She presented to the hospital 1/1/22 at which point she was diagnosed with acute COVID-19. She became ill before she could complete the series
Acute onset left periauricular/mandibular swelling and pain. Occurred within first hour following vaccination so administer 25mg of Benadryl, with no change. No redness, rash, fever or other symptoms. Watching for 24h to see if further examination (ie imaging) or intervention (ie antibiotics) is indicated given prior history of R parotitis.  Also moved scopolamine patch from behind left ear to behind R ear in case this was somehow correlated.
Fever & abdominal distention with explosive stools, abd ultrasound = some bowel distension with minimal amounts of extra fluid scattered throughout bowel, no intussusception, nl UA, nl CBC, CRP = 1.4 (high).
Decreased vision OD > OS related to optic neuropathy - likely optic neuritis.
My arm was very hot, hard, swelled up, and painful. My lymph nodes under my left arm also swelled up and we're severely painful. It has been 3 days since my vaccination, and my arm and lymph nodes are still incredibly painful. Although I am feeling considerably better, as I had most of the common side effects, I still have a fever, sore joints and muscles, and fatigue. The booster was even worse for me than first two shots!
Jabbing excruciating pain like someone stabbed me with an icepick in the center of left calf. Jabbing pain in Brachial Plexus of right shoulder blade area with numbness in my right arm.
This case for 3 patients is part of cluster of 2 cases and linked with case number 2013SA136392 (one patient). Initial report received from a healthcare professional on 26 December 2013. 3 female patients in the age group of 21-50 had received an intradermal dose of FLUZONE ID (lot number, dose number and anatomical site of administration were not reported) on an unspecified date of November 2013. The patient had no illness at the time of vaccination and concomitant medications were not reported. On 24 December 2013, the patients were suspected to have flu with symptoms of fever (103), achiness and weakness. Laboratory details and corrective treatments were not reported. At the time of this report, the patient had not recovered from events. Documents held by sender: none.
First noticed symptoms after waking up during the night roughly 14 hours after receiving the 2nd dose of the vaccine. Felt EXTREMELY fatigued and my heart was racing. Fell back asleep and woke up again around 8am. Symptoms persisted. Extremely tired and fatigued and heart was beating fast. Resting heart rate of around 100bpm which jumped to 120bpm when I moved at all (including just rolling over in bed). This persisted throughout the day, and I stayed in bed. In the early afternoon (about 24 hours after 2nd vaccine dose) I started to feel aches in neck and back and started a headache. Took my temperature and had a fever (101). Aches/headache continued to get worse throughout the afternoon. Finally around 4:30pm I found my Tylenol and took a dose. This substantially helped reduce all my symptoms; although I was still tired, it was much less than earlier in the day. Took a dose of Advil around 7:30pm and went to bed about an hour later. By morning, my symptoms were practically all gone, I was just slightly more tired than normal that day (2nd day after vaccine). I did not take any more medication.
Patient reported he had moderate pain 3 hours after being vaccinated in his right arm from shoulder to elbow. Soon after, he reports that he had excruciating pain in same arm and immediately went to ER where they told him to take Tylenol.
Child developed sudden onset of fever and lethargy which lasted over one week.  Decreased appetite and cough. Headache and SOB.
No adverse event.  Patient was administered Covid-19 vaccine on 6/21/2022 and the vaccine expired on 6/3/2022.  Scheduled for revaccination.
Systemic: Chills-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Systemic: Nausea-Medium, Systemic: Weakness-Medium
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with PNEUMOVAX 23. Dose, route, lot number and expiration date were not reported. The nurse reported that PNEUMOVAX 23 was improperly stored and was administered to unspecified number of patients. No adverse effects reported. This is one of several reports from the same source. Additional information is not expected. No allowed to contact physician.
mom in today for pts last DTP of series & states should put it off because w/last vax had sz 9 days later; t104.2 R; mom felt twitch & stiff then started growling & then had obvious sz; pt taken to MD & probably was unconscious for 10 mins;
hot; redness; good red; uncomfortable; hardness; swollen; injection site turn red; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot), ERYTHEMA (redness), ERYTHEMA (good red), FEELING ABNORMAL (uncomfortable) and VACCINATION SITE INDURATION (hardness) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site). On 29-Mar-2021, the patient experienced VACCINATION SITE WARMTH (hot), ERYTHEMA (redness), ERYTHEMA (good red), FEELING ABNORMAL (uncomfortable), VACCINATION SITE INDURATION (hardness), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE ERYTHEMA (injection site turn red). On 20-Mar-2021, VACCINATION SITE PAIN (pain at the injection site) had resolved. On 05-Apr-2021, VACCINATION SITE WARMTH (hot), ERYTHEMA (redness), ERYTHEMA (good red), FEELING ABNORMAL (uncomfortable), VACCINATION SITE INDURATION (hardness), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE ERYTHEMA (injection site turn red) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment include Benadryl at night  and Cetrizina at morning
Starting at 3:00AM on Sept 29 I began to have SEVERE lower back pain, chills, nausea, headache, fever, loss of appetite for 3 days, and severe left arm pain.
left index finger feels like it was jammed; finger was in a lot of pain when moving left or right, even when washing his hands; This is a spontaneous report from a contactable consumer (patient). A 37-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: not reported), via an unspecified route of administration on 03Feb2021 at 19:45 at a single dose on the arm left for COVID-19 immunization. Medical history included patient was diagnosed with COVID-19. Concomitant medications included naproxen sodium (ALEVE) and biotin. On 04Feb2021 at 03:00, the patient stated that his left index finger feels like it was jammed. The patient also stated that his finger was in a lot of pain when moving left or right, even when washing his hands. The patient did not receive any treatment for the reported events. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovering. The events were assessed as non-serious.  Information on the lot/batch number has been requested.
I had an incidental interaction w/patient this AM at approx. 8:30 AM, following the monthly staff meeting where she asked me "if she's supposed to tell me about a "reaction" she got from the flu vaccine" (I confirmed she did receive the vax here on 10/14/14 at approx. 5 AM - as she recalls). I asked her if she reported it thru her PCP and she said she had called to report her symptoms but they did not want to see her - it is unclear to me when she placed this call to her MD office in response to her symptom development. She reports the following symptoms with the approximate time of presentation: - "Itching" - developed 1 hour (6AM) after flu vax given - did not report this to RN on duty - "Hives" - developed 2-3 hours (7-8 AM) after flu vax was given - did not report this to RN on duty - Weakness and Numbness in her Left Arm (site of injection) "by the time she got home" - she could hardly open the door to her vehicle" - did not report to this nurse until 11/12/14 and is resolved. - Temp of 101 (I did not verify w/her that this was not 100.1, but 101) - developed at Midnight the following night after the vaccine was administered, while here at work. She states she reported this to her supervisor, and another staff RN gave her TYLENOL while here at work to treat the fever and she continued to work her shift. - She denies being sick the day of the injection; Denies allergy to eggs, egg products or chicken feathers, gelatin, or thimerosal. - She reports her only allergy as AUGMENTIN. Patient was asked to contact her PCP to assure that they hadn't followed up by completing VAERS reporting (based on her report, it was unsure to me if she actually spoke to the office, was seen by a provider or not) and to let me know if this was not reported, b/c of the need for follow up with VAERS. She agreed to do so and get back to me. She returned to my office approx. 20 minutes later and said she had called her Dr and per her "they have no report in her file of her having called in to report these symptoms". I did verify with her that she did NOT go any urgent care of ED for treatment of anaphylaxis. She states she did not. She does not admit to taking any medication post vaccination (Ex: BENADRYL to treat symptoms, only TYLENOL). She denied any long lasting adverse effects at this time and reports she is back to baseline.
Client vaccinated with Moderna vaccines on May 1 and June 1, 2021.  Symptoms of Covid on 11/22/2021 - runny nose, loss of taste and smell.  Vaccinated person who has breakthrough Covid illness.
Noticed rash in inner elbow on right arm approx 27 hours post-injection. Red welt approximately penny sized. Not itchy. Spread to right wrist and neck 39 hours post-injection. Subsequent spots were clusters of tiny red spots (ball point pen size). Spread to chest, right thigh (welt quarter sixes), right leg, and right foot 50 hours post-injection. Mild rash on inner left arm at 50 hours, no clusters just single dots all over arm.
Narrative:  Presented to hospital for evaluation of adverse reaction involving right posterior neck pain/numbness and right-sided chest wall and abdominal pain/paresthesia after 1st covid vaccine. Went to loval ER and had evaluation including negative CT head per history.
ED Note: "presents to the ED via RRT from pre-op after having a left SI injection with complaints of a stroke alert. at 1132 this morning. Per NP from pre-op, the pt received the injection without issue. After the injection she was developed groin numbness, which progressed into a headache, and chest pain. She then became aphasic, with left sided weakness and numbness. BS was 154 at that time. Per husband at bedside, the pt had numbness and tingling after injection but was otherwise at baseline. While the pt was getting dressed, the husband went to get the car. He notes the pt is on Xarelto secondary to PE and has taken it as prescribed. He denies any missed doses but states he is unsure of what time the last dose was. He states that the pt has no lasting deficits from her prior stroke. Of note, the pt is able to respond by nodding yes or no but is unable to speak.  Pt able to write on a white board. She states she was taken off the Xarelto 3 months ago. The pt states she is unable to talk. She endorses left arm and leg weakness. The pt states she has a prior stoke years ago with weakness but has no lasting deficits. "   Admitted to the hospital  Diagnoses:   -Dysphasia -Small vessel cerebrovascular disease -Bereavement -Vitamin-D deficiency
This study case was received from the investigator on 19 August 2011. A 24-year-old male subject received on 12 May 2011 the following vaccination: an injection of ACAM2000 (lot number not reported). The subject has no significant medical history. On 24 May 2011, the subject had an abnormal Troponin I of 04.80 and an abnormal electrocardiogram (ECG). On 27 May 2011, the patient had an echocardiogram which was abnormal. On 09 June 2011, the subject was diagnosed with acute pericarditis, unspecified. The outcome was not reported. Additional information will be requested from the investigator. There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: None.
Evident cellulitis at the injection site. The area of cellulitis appears to be about 3x3 inches wide. Red and lightly swelled. It did not seem hot to touch. Was not painful for patient.
she wants to throw up; she is tired; she has a headache; she is not feeling well; The lymph node is swollen under her arm pit.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in arm left, administration date 13Mar2021 11:45 (Lot number: NFB199) at the age of 43 years as dose 2, single for COVID-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Lot: EM9809), administration date: 20Feb2021, for COVID-19 immunisation.  The following information was reported: VOMITING (non-serious), outcome "unknown", described as "she wants to throw up"; FATIGUE (non-serious), outcome "unknown", described as "she is tired"; HEADACHE (non-serious), outcome "unknown", described as "she has a headache"; MALAISE (non-serious), outcome "unknown", described as "she is not feeling well"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "The lymph node is swollen under her arm pit.".  Additional information: The events did not require a visit to emergency room and physician office.   No follow-up attempts are possible. No further information is expected.
injection site soreness ~4 hours after vaccine injection; Fatigue set in ~12 hours after vaccine injection; Chills set in ~14 hours after vaccine injection; feverish ~17 hours after injection
Moderna Booster, patient reporting fever for 3 days, body aches, pain in armpit (swollen Lymph node), Still has lymph node, swelling has decreased, headaches, light headedness, also was in close contact with someone with COVID.
He remains ill, even now; Severe diarrhea x5 days; Weakness; Headache; Stomach ache; Nausea; Joint pain; This is a spontaneous report from a contactable consumer. A male patient (reporter's brother-in-law) of an unspecified age received bnt162b2 (Pfizer-BioNTech Covid-19 vaccine) via an unspecified route of administration as a single dose on 08Apr2021 (lot number unknown) at an unknown age for COVID-19 immunization. The patient's medical history included diabetes. Concomitant medications was none. On that day (08Apr2021), the patient had severe diarrhea for 5 days. He also experienced weakness, headache, stomach ache, nausea, and joint pain. He remained ill, even now (in May2021). He got tested for Covid-19, which was negative (in 2021). The reporter thought maybe he had gotten Covid-19 before the vaccine. They thought his reaction was bad, because of his diabetes, his levels were high. He took Tylenol and Motrin. The outcome of the events was unknown.  Information on the lot/ batch number has been requested.
It started with runny nose and sneezing and some coughing with a sore throat. I also had frequent urgent urination about once an hour. It was very unpleasant as I was also experiencing chills. It was the same the next night but then it got smooth. I did not have a fever, but I do get chills very easily. I completed a home COVID-19 test that was positive on 02/23/2023. I called my doctor and was prescribed PAXLOVID. I had a profound diarrhea which I believe were contributed by the drug. It took about 2 days for my symptoms to improve. I slowly but progressively started to feel better. It took a sold week before I felt more normal.
pt recvd vax 7JAN93 & 2 hrs p/vax devel a rash on face & neck & generalized itching; pt exp required no treatment & sx subsided w/in 3 days;
Blood clot/sinus thrombosis; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 20-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 17Nov2021 at 14:00 as dose 3 (booster) , single (Batch/Lot number: unknown) at the age of 19 years, in right arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: EP6955, Location of injection: Arm Left, Vaccine Administration Time: 11:00 AM), administration date: 25Mar2021, when the patient was 19-year-old, for COVID-19 Immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion, Location of injection: Arm Right, Vaccine Administration Time: 05:00 PM), administration date: 02Feb2021, when the patient was 18-year-old, for COVID-19 Immunization. The following information was reported: THROMBOSIS (hospitalization, medically significant, life threatening) with onset 02May2022 at 12:00, outcome "not recovered", described as "Blood clot/sinus thrombosis". The patient was hospitalized for thrombosis (hospitalization duration: 4 day(s)). The event "blood clot/sinus thrombosis" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (03May2022) Negative, notes: Nasal Swab. Therapeutic measures were taken as a result of thrombosis with Blood thinners.  Clinical information: Blood thinners given as a treatment. The patient did not have covid prior vaccination. She tested for covid post vaccination (result: Negative). She did not have known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200735242 Same patient and drug, different event separated in time
body pain; chills; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received bnt162b2 (BNT162B2), administration date 04Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "unknown", described as "body pain"; CHILLS (non-serious), outcome "unknown", described as "chills"; HEADACHE (non-serious), outcome "unknown", described as "headache".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt had active shingles outbreak & pt was immunized. Pt believes it caused him to get disoriented & weak & was taken to ER & spent 4 days in the hospital.
Breakthrough case admission after 5 vaccines Pfizer 2/11/21 Lot# EM9810;  Pfizer 3/4/21 Lot# EN6201;  Pfizer 11/16/21 Lot# Ew0172;  Pfizer 4/6/22 Lot# FK9896;  Pfizer 9/15/22 Lot# GH9694
Patient presented to the ER for worsening SOB, cough, nausea and diarrhea. Diagnosed with acute respiratory failure and pneumonia related to Covid-19. Patient was placed on 5L NC in the ER. CRP 11.51, Ferritin 403, D-Dimer 0.94. Patient received Remdesivir but had to be discontinued early due to bradycardia. Patient received Decadron. Patient discharged home on home o2.
Pharyngitis, odynophalgia, nausea, vomiting, decrease appetite, dizziness.
has a lump at the site where vaccine was administered; started scratching the arm at the injection site; This is a spontaneous report from a contactable consumer (patient). An elderly female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL9263), via an unspecified route of administration on 29Jan2021 at 16:45 at a single dose in the left arm for COVID-19 immunization. Medical history included rheumatoid arthritis (RA), hypertension, and allergies. Concomitant medications were not specified. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 05Feb2021, the patient started scratching the arm at the injection site and has a lump at the site where vaccine was administered. The patient did not receive any treatment for the reported events. Since the vaccination, the patient has not been tested for COVID-19. The patient was not pregnant at the time of vaccination. The outcome of the events was unknown.
Information has been received from a registered nurse concerning a female who on 24 Oct 2006 was vaccinated with Gardisil (yeast) (Lot #654540/0800F). The nurse reported that on 24 Oct 2006 the pre-filled syringe of the vaccine malfunctioned and small amount sprayed out of the syring while she was withdrawing the syringe and the patient received an incomplete dose of the vaccine. She thought most of the dose was administered. The patient also stated that "the vaccination hurt." Unspecified medical attention was sought. At the time of this report the patient's outcome was unknown. Additional information has been requested. 01/05/2007 Information has been received from a registered nurse concerning a 18 year old female who at 12:30 on 24-OCT-2006 was vaccinated intramuscularly in the deltoid with GARDASIL (Lot#654540/0800F). The nurse reported that on 24-OCT-2006 the pre-filled syringe of the vaccine malfunctioned and a small amount sprayed out of the syringe while she was withdrawing the syringe and the patient received  an incomplete dose of the vaccine. She thought most of the dose was administered. The patient also stated that "the vaccination hurt". Unspecified medical attention was sought. At the time of this report the patient's outcome was unnknown. Additional information has been requested.